Australia's Anatara Lifesciences falls on discounted placement

Anatara Lifesciences

01/05/2024 03:46

** Shares of Australia's Anatara Lifesciences  ANR.AX  fall
as much as 6.3% to A$0.045, marking its biggest intraday pct
decline since April 22
    ** Stock hits its lowest level since April 23
    ** Gastrointestinal health products maker receives
commitments to raise A$1.0 mln ($647,100.00) placement at issue
price of A$0.04 per share
    ** Issue price represents a discount of 16.7% to stock's
last closing
    ** Around 28,988 shares change hands as of 0238 GMT, vs
30-day average volume of 272,304 shares
    ** Stock up 118.2% YTD, as of last close

($1 = 1.5454 Australian dollars)

 (Reporting by Roshan Thomas in Bengaluru)
 ((Roshan.Thomas@thomsonreuters.com))